IBEC staff gather for IBEC Day to mark the institute’s 20th anniversary
Over 200 people took part in IBEC Day 2026, an event designed to encourage sharing, connection and celebration in honour of the institute’s 20th anniversary.
Javier Ramon
Group leader
IBEC showcases cutting-edge biomedical innovation at the Health Revolution Congress 2026
The Institute for Bioengineering of Catalonia brought together researchers, investors and industry leaders with its event “IBEC Health Revolution Day: Engineering the Future of Medicine”, as part of the Health Revolution Congress. Through expert panels, technology pitches and scientific talks, the event showcased cutting-edge biomedical technologies and discussed how to translate scientific discoveries into real-world healthcare solutions.
Together with Patients with Duchenne, IBEC is developing a ‘heart-on-a-chip’ to halt the cardiac damage caused by the condition
Duchenne Parent Project Spain has invested €247,000 in the BEAT project, which will be carried out by the Institute for Bioengineering of Catalonia (IBEC). Cardiomyopathy is the leading cause of death in patients with Duchenne muscular dystrophy (DMD). Around 20,000 new Duchenne cases are diagnosed globally each year.
IBEC makes its mark at TERMISEU 2026 with a strong scientific presence and a key role in the conference’s leadership
From 21 to 24 April 2026, IBEC had a significant presence at TERMISEU 2026, the leading European conference on tissue engineering and regenerative medicine. Held at the Palma Conference Centre in Mallorca, the event brought together more than 1,600 researchers.
BIST calls for reforms to turn scientific discoveries into European industry
The BIST Forum 2026 brought together scientists and representatives from academic, economic and social institutions to discuss how frontier research can help build Europe’s industries of the future. The event also announced the recipients of the BIST To the Mothers of Science and Ignite programmes.
IBEC secures competitive funding to drive forward validation testing for three innovative health projects
IBEC has been awarded three grants in response to the call for proposals from the Strategic Plan for Health Research and Innovation (PERIS). These projects aim to validate hyperspectral technology for improving assisted reproduction, using bioprinted cell spheroids to combat type 1 diabetes and developing light-activated drugs to restore vision in patients with retinal degeneration.
The IBEC and West China Hospital hold their third joint conference on precision medicine in Barcelona
Barcelona hosted the third IBEC-WCH Precision Medicine Conference this week, an event that further strengthened the strategic alliance between the Institute for Bioengineering of Catalonia (IBEC) and the West China Hospital of Sichuan University (WCHSU). The Chinese delegation visited Spain from 26 to 29 November, taking part in a busy schedule of scientific and institutional activities and exchanges between the two centres.
Fibrosens Project receives funds from AFM-Telethon to develop sensor devices for muscular dystrophy
IBEC researcher Juanma Fernández recently has received funding from the French AFM-Telethon to carry out the project “Monitoring of fibrotic processes in 3D skeletal muscle co-cultures for Muscular Dystrophies using plasmonic biosensors”. The objective is to develop multiplexing sensor devices to achieve online, real-time sensing capability to monitor fibrosis markers and evaluate drug response in muscular dystrophy in vitro models.
IBEC science reaches thousands at the 43rd Comic Barcelona
The Institute for Bioengineering of Catalonia (IBEC) was a major presence at the 43rd Comic Barcelona last week. Through an exhibition on everyday science, talks and informative workshops, IBEC was able to bring its cutting-edge research to an audience of all ages.
IBEC and SJD Barcelona Children’s Hospital strengthen their collaboration with a day of translational innovation
The Institute for Bioengineering of Catalonia and the Sant Joan de Déu Barcelona Children’s Hospital have held a joint conference to strengthen collaboration in bioengineering and translational medicine. The event, held this morning at the IBEC, highlighted innovative projects, presented a joint PhD programme and encouraged the exchange of ideas between researchers from both institutions.